ResMed (NYSE:RMD) Upgraded at StockNews.com

StockNews.com upgraded shares of ResMed (NYSE:RMD – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday. A number of other brokerages have also weighed in on RMD. Oppenheimer lowered shares of ResMed from an outperform rating to a market perform rating in a report on Tuesday, […]

Leave a Reply

Your email address will not be published.

Previous post Sempra (NYSE:SRE) Updates FY25 Earnings Guidance
Next post JPMorgan Chase & Co. Increases Post (NYSE:POST) Price Target to $125.00